# Premna odorata (Premna odorata Blanco)

**Canonical URL:** https://ingredients.hermeticasuperfoods.com/ingredients/premna-odorata-premna-odorata-blanco
**Data Source:** Hermetica Superfoods Ingredient Encyclopedia
**Updated:** 2026-04-02
**Evidence Score:** 1 / 10
**Category:** Middle Eastern
**Also Known As:** Premna odorata Blanco, Alagaw, Malabar, Premna cumingiana, Fragrant premna

## Overview

Premna odorata contains bioactive flavonoids (linarin, casticin, tricin), phenylpropanoids (verbascoside), and terpenoids (α-amyrin, trans-phytol) that exert antimycobacterial, apoptotic, and [anti-inflammatory](/ingredients/condition/inflammation) effects through NF-κB inhibition, caspase activation, and cell-cycle arrest pathways. Its n-hexane leaf fraction demonstrated a minimum inhibitory concentration of 100 μg/mL against Mycobacterium tuberculosis in vitro, inhibiting bacterial growth by 71% at 12.5 μg/mL compared to 93% for the reference drug isoniazid.

## Health Benefits

- **Anti-Tuberculosis Activity**: The n-hexane leaf fraction inhibits Mycobacterium tuberculosis with an MIC of 100 μg/mL, with 71% growth inhibition at 12.5 μg/mL in laboratory assays, supporting its traditional use against pulmonary infections.
- **Anticancer Potential (Glioma)**: The flavone linarin induces apoptosis in A172 and U251 glioma cell lines at 70–80 μM by upregulating p53, p21, Bax, and Caspase-3 while activating PARP-1, suggesting pro-apoptotic activity in brain cancer models.
- **Lung Cancer Cell Suppression**: Linarin suppresses NF-κB activation and matrix metalloproteinase-9 (MMP-9) expression in A549 non-small-cell lung cancer cells at 282 μM, potentially limiting invasion and inflammatory signaling.
- **Nasopharyngeal Carcinoma Cell Cycle Arrest**: The flavonoid casticin induces G2/M phase arrest in S18 nasopharyngeal carcinoma cells at 8–16 μM concentrations, increasing pro-apoptotic Bax and decreasing anti-apoptotic Bcl-2 expression.
- **Antioxidant Activity**: Ethanolic extracts contain total phenolic compounds at 7.56–8.24% gallic acid equivalents and antioxidants at 4.92–6.66% ascorbic acid equivalents, supporting [free radical scaveng](/ingredients/condition/antioxidant)ing capacity relevant to oxidative stress-related conditions.
- **Traditional Analgesic and Antipyretic Use**: Ethnomedicinal records document use of leaf preparations for headache, stomach pain, and fever management across Filipino and Southeast Asian folk medicine, consistent with the [anti-inflammatory](/ingredients/condition/inflammation) properties of verbascoside and β-caryophyllene.
- **Antiparasitic and Wound-Healing Applications**: Traditional preparations have been applied topically and orally for parasitic infections and wound care, consistent with the broad-spectrum [antimicrobial](/ingredients/condition/immune-support) properties attributed to its terpenoid and phenylpropanoid constituents.

## Mechanism of Action

Linarin, a flavone glycoside, suppresses NF-κB transcriptional activation in lung cancer cells, reducing downstream expression of MMP-9 and [pro-inflammatory cytokine](/ingredients/condition/inflammation)s, while simultaneously activating the intrinsic apoptotic pathway via upregulation of p53, p21, and Bax with concurrent Caspase-3 and PARP-1 cleavage in glioma models. Casticin induces G2/M cell-cycle arrest by modulating Bax/Bcl-2 ratio, pushing cells toward mitochondria-mediated apoptosis rather than permitting uncontrolled proliferation. The anti-tuberculous activity of the n-hexane fraction — dominated by trans-phytol (24.06%), n-octacosane (15.28%), and α-amyrin (13.37%) — is attributed to disruption of mycobacterial cell wall integrity and membrane permeability, though the precise molecular target within Mycobacterium tuberculosis has not been fully characterized. Verbascoside, a phenylpropanoid, contributes antioxidant and anti-inflammatory effects through inhibition of [reactive oxygen species](/ingredients/condition/antioxidant) generation and modulation of arachidonic acid [metabolism](/ingredients/condition/weight-management), while β-caryophyllene selectively binds CB2 cannabinoid receptors to exert peripheral anti-inflammatory effects.

## Clinical Summary

No human clinical trials have been conducted on Premna odorata or its isolated bioactive constituents for any indication as of current literature. All mechanistic and efficacy data originate from in vitro assays using cancer cell lines and microbiological growth inhibition assays against M. tuberculosis, which represent early-stage preclinical evidence only. Effect sizes reported — such as 71% mycobacterial growth inhibition at 12.5 μg/mL and IC50 values for flavonoids in the low micromolar range — are promising from a drug discovery perspective but cannot be extrapolated to human therapeutic outcomes without pharmacokinetic, bioavailability, and toxicological studies. Confidence in any clinical benefit is therefore very low, and the ingredient's medicinal value remains hypothetical beyond its documented traditional ethnomedicinal use.

## Nutritional Profile

Premna odorata leaves contain a diverse array of phytochemicals rather than significant macronutrient content. The n-hexane fraction is dominated by trans-phytol (24.06%), a diterpene alcohol and chlorophyll derivative; n-octacosane (15.28%), a long-chain alkane; and α-amyrin (13.37%), a pentacyclic triterpenoid — together comprising 52.71% of the ten major compounds that account for 93.01% of the fraction. Flavonoid constituents include acacetin, diosmetin, linarin, tricin, and casticin, while sterols include stigmasterol and β-sitosterol, the latter being a known phytosterol with cholesterol-modulating properties. Ethanolic extracts show moderate total phenolic content (7.56–8.24% as gallic acid equivalents) and [antioxidant](/ingredients/condition/antioxidant) capacity (4.92–6.66% as ascorbic acid equivalents). Bioavailability of these compounds in humans has not been studied for this specific plant; however, flavonoid glycosides such as linarin typically require intestinal deglycosylation by gut microbiota before absorption, and terpenoids like α-amyrin generally exhibit low oral bioavailability without lipid-based delivery systems.

## Dosage & Preparation

- **100% Ethanolic Extract (Leaf)**: No standardized human dose established; research extracts yielded 3.23–5.25% premnaodoroside A, 7.56–8.24% total phenolics, and 4.92–6.66% [antioxidant](/ingredients/condition/antioxidant)s — noted as potentially 'convenient for medicinal administration at a lower dose with high potency' but without specific mg/kg or adult dosing protocols.
- **80% Ethanolic Extract (Leaf)**: Produces higher extractive yield than 100% ethanol but lower concentrations of key bioactives; used in comparative phytochemical studies, no dosing recommendation available.
- **n-Hexane Leaf Fraction**: Used in anti-tuberculosis assays at concentrations of 12.5–100 μg/mL in vitro; no equivalent oral dose for humans has been established or validated.
- **Traditional Decoction (Folk Medicine)**: Leaves are boiled in water and consumed as a tea for cough, phlegm, and fever in Filipino traditional medicine; preparation ratios and volumes are not standardized in the ethnomedicinal literature.
- **Topical Poultice (Wound Use)**: Crushed fresh leaves applied directly to wounds and skin infections in Southeast Asian folk practice; no standardized formulation or frequency of application documented.
- **Important Note**: No pharmacokinetic data, bioavailability studies, or clinically validated dosing protocols exist for any form of Premna odorata.

## Safety & Drug Interactions

No formal clinical safety studies, adverse event reporting, or toxicological dose-escalation trials have been published for Premna odorata in humans, meaning the safety profile is essentially uncharacterized by modern pharmacological standards. ADME and TOPKAT computational toxicity predictions were noted in the literature for trans-phytol, but specific results were not detailed, leaving predicted safety margins unconfirmed. No drug interaction studies exist; however, given the presence of [NF-κB](/ingredients/condition/inflammation)–inhibiting flavonoids (linarin), theoretical caution is warranted with concurrent immunosuppressive medications, anticoagulants (flavonoids may affect platelet aggregation), or cytochrome P450-metabolized drugs, though no interaction has been empirically documented. Pregnancy and lactation safety is entirely unknown, and the absence of any reproductive toxicology data means use during pregnancy should be avoided; individuals with autoimmune conditions, those undergoing chemotherapy, or patients on anti-tuberculosis drug regimens should consult a qualified healthcare provider before use.

## Scientific Research

The current evidence base for Premna odorata consists exclusively of in vitro cell culture studies and phytochemical metabolomic profiling; no human clinical trials or peer-reviewed animal (in vivo) pharmacological studies have been published in the indexed literature as of the most recent search. Anti-tuberculous activity was quantified in laboratory MIC assays comparing the n-hexane leaf fraction to isoniazid, demonstrating a four-fold higher MIC (100 μg/mL vs. 25 μg/mL), which indicates meaningful but substantially weaker activity than the reference drug. Anticancer mechanistic data derives from established cancer cell line models (A172, U251, A549, S18, PC3), providing proof-of-concept for apoptotic and anti-proliferative activity but not translatable clinical efficacy. Researchers explicitly acknowledged that 'the absence of comprehensive in vivo and clinical data warrants further research,' underscoring that all quantified outcomes reported reflect bench-level findings with no established therapeutic relevance in humans.

## Historical & Cultural Context

Premna odorata holds an established place in Philippine indigenous medicine, where it is commonly known as 'Alagaw' or 'Malabar' and has been used by local healers for generations to treat respiratory complaints including cough, phlegm, and tuberculosis-like illnesses, as well as gastrointestinal conditions such as stomach pain and parasitic infections. The plant's traditional application against tuberculosis is particularly notable given the historical prevalence of the disease in the Philippines and neighboring Southeast Asian nations, lending ethnopharmacological plausibility to modern laboratory investigations of its antimycobacterial properties. Across broader tropical Asia, related Premna species have similarly been incorporated into Ayurvedic and traditional Chinese medicine systems, often as components of multi-herb formulations for fever and [inflammatory](/ingredients/condition/inflammation) conditions. The fragrant flowers and aromatic leaves made the plant identifiable and culturally memorable, contributing to its sustained use and transmission of knowledge across generations of traditional practitioners.

## Synergistic Combinations

In traditional Filipino multi-herb formulations, Premna odorata leaves are sometimes combined with other aromatic and [antimicrobial](/ingredients/condition/immune-support) plants such as Vitex negundo (lagundi), which shares flavonoid constituents and complementary [anti-inflammatory](/ingredients/condition/inflammation) mechanisms via NF-κB and COX-2 inhibition, potentially producing additive respiratory and antimicrobial effects. The β-sitosterol content may synergize with other plant sterols to enhance cholesterol displacement and anti-inflammatory signaling at intestinal and systemic levels, a principle well-documented for phytosterol combinations. Given the role of trans-phytol as a chlorophyll derivative with [antioxidant](/ingredients/condition/antioxidant) properties, pairing with other polyphenol-rich botanicals could theoretically enhance redox buffering, though no empirical synergy studies have been conducted specifically for Premna odorata combinations.

## Frequently Asked Questions

### Does Premna odorata actually kill tuberculosis bacteria?

In laboratory (in vitro) assays, the n-hexane leaf fraction of Premna odorata demonstrated a minimum inhibitory concentration (MIC) of 100 μg/mL against Mycobacterium tuberculosis, inhibiting bacterial growth by 71% at 12.5 μg/mL. By comparison, the reference drug isoniazid showed an MIC of 25 μg/mL and 93% inhibition at the same concentration, meaning the plant extract was measurably less potent. No human clinical trials have tested Premna odorata against tuberculosis, so it cannot be recommended as a substitute for standard anti-TB therapy.

### What are the main active compounds in Premna odorata?

The primary bioactive compounds include flavonoids (linarin, casticin, tricin, acacetin, diosmetin), the phenylpropanoid verbascoside, sterols (β-sitosterol, stigmasterol), and terpenoids including α-amyrin, trans-phytol, and β-caryophyllene. In the n-hexane leaf fraction, trans-phytol (24.06%), n-octacosane (15.28%), and α-amyrin (13.37%) are the dominant compounds. The unique iridoid glycoside premnaodoroside A, found at 3.23–5.25% in ethanolic extracts, is considered a phytochemical marker for this species.

### Is Premna odorata safe to use as a supplement?

The safety profile of Premna odorata has not been formally evaluated in human clinical trials, and no standardized dosing protocols or toxicological thresholds have been established. While it has a long history of traditional use in Filipino folk medicine with no widely reported acute toxicity, the absence of pharmacokinetic and safety data means it cannot be deemed safe by modern regulatory standards. Individuals who are pregnant, breastfeeding, taking prescription medications, or managing active tuberculosis should avoid use without guidance from a licensed healthcare professional.

### Can Premna odorata be used for cancer treatment?

Premna odorata's flavonoids — particularly linarin and casticin — have shown anticancer activity in cell culture models, inducing apoptosis in glioma, lung cancer, and nasopharyngeal carcinoma cell lines at micromolar concentrations. However, these are entirely in vitro findings from laboratory assays, and no animal studies or human clinical trials have been conducted to evaluate efficacy or safety in cancer patients. The ingredient should not be used as a cancer treatment or adjunct therapy outside of a supervised clinical research setting.

### How is Premna odorata traditionally prepared and used?

In traditional Filipino and Southeast Asian folk medicine, Premna odorata (locally called Alagaw) is most commonly prepared as a leaf decoction — boiling fresh or dried leaves in water to produce a tea consumed for cough, phlegm, fever, stomach pain, and tuberculosis-like symptoms. Leaves are also crushed into a poultice for topical application to wounds and skin infections. Modern phytochemical research suggests that 100% ethanolic extraction yields the highest concentrations of bioactive compounds including premnaodoroside A and total phenolics, making it more potent than water-based preparations, though no standardized supplement form is commercially available.

### Does Premna odorata interact with tuberculosis medications like rifampicin or isoniazid?

There is currently no published research on potential interactions between Premna odorata and standard TB medications. Because Premna odorata shows in vitro activity against Mycobacterium tuberculosis, concurrent use with prescription TB drugs should only be undertaken under medical supervision to avoid redundant or antagonistic effects. Patients being treated for active tuberculosis should consult their healthcare provider before adding this herb to their regimen.

### Is Premna odorata safe to use during pregnancy or while breastfeeding?

There are no safety studies evaluating Premna odorata use in pregnant or breastfeeding women. Given the lack of clinical data and the herb's bioactive compounds, it should be considered contraindicated or used only under medical guidance during pregnancy and lactation. Women in these populations should consult with a healthcare provider before considering supplementation.

### What is the current quality of evidence for Premna odorata's health benefits in human studies?

Most evidence for Premna odorata comes from laboratory and in vitro studies rather than clinical trials in humans. While its traditional use against tuberculosis and preliminary findings in glioma cell cultures are promising, high-quality randomized controlled trials in human subjects are needed to confirm efficacy and safe dosing. The herb remains primarily supported by ethnobotanical use and preclinical research rather than definitive clinical proof.

---

*Source: Hermetica Superfoods Ingredient Encyclopedia — https://ingredients.hermeticasuperfoods.com*
*License: CC BY-NC-SA 4.0 — Attribution required. Commercial use: admin@hermeticasuperfoods.com*